[Diabetic polyneuropathy treatment by milgamma-100 preparation]

Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(9):30-2.
[Article in Russian]


Efficiency of Milgamma-100 preparation (100 mg of benfothiamine + 100 mg of pyridoxin) was studied in treatment of diabetic polyneuropathy in 14 patients with diabetes mellitus type II (1 dragee 3 times a day, within 6 weeks). After the course of treatment the intensity of pains was decreased according to visual analogous scale on the average from 8.2 to 2.3 scores, the indices of vibratory sensitivity improved significantly as well as the data of cardiovascular tests characterizing parasympathetic control of heart rhythm. Meanwhile latent periods of the evoked sympathetic potentials on arms and legs which were initially lengthened became significantly shorter. A clear-cut tendency was also found to increasing conduction rate for excitation through the motor nerves. The treatment resulted in the improvement of the condition in 93% of the cases. The conclusion was made about efficiency and safety of Milgamma-100 preparation application in therapy of patients with diabetic polyneuropathy.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Chelating Agents / therapeutic use*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Neuropathies / complications
  • Diabetic Neuropathies / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Heart Rate
  • Humans
  • Male
  • Pyridoxine / therapeutic use*
  • Thiamine / analogs & derivatives*
  • Thiamine / therapeutic use
  • Treatment Outcome


  • Chelating Agents
  • Pyridoxine
  • Thiamine
  • benphothiamine